Patients undergoing bypass surgery are often given a clotting
drug. Two studies suggest that the risk of a post-surgery stroke,
heart attack, or kidney failure is substantially higher after
receiving one such drug, Trasylol.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.